Literature DB >> 24417797

Hypomyelinating leukodystrophy-associated missense mutant of FAM126A/hyccin/DRCTNNB1A aggregates in the endoplasmic reticulum.

Yuki Miyamoto1, Tomohiro Torii1, Takahiro Eguchi2, Kazuaki Nakamura1, Akito Tanoue1, Junji Yamauchi3.   

Abstract

Hypomyelinating leukodystrophies (HLD) are hereditary central nervous system diseases in which the myelin sheath does not form properly. The disease prototype is the X-linked recessive Pelizaeus-Merzbacher disease (also now known as HLD1), which is caused by the mutation, multiplication, or deletion of the plp1 gene. PLP1 missense mutations lead to protein aggregation and accumulation in subcellular compartments such as the endoplasmic reticulum (ER). The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named fam126a (also known as hyccin or drctnnb1a). While the gene mutations often cause FAM126A protein deficiency, one known missense mutation, Leu-53-to-Pro (L53P), allows some protein to be produced. Here, we show that the L53P mutant aggregates in cells, accumulating primarily in the ER. This is in contrast to the wild type FAM126A, which distributes throughout the cytoplasm. In addition, the L53P mutant expression promotes the activities of kinases involved in unfolded protein response. These results suggest that a disease-associated FAM126A missense mutation causes protein accumulation in subcellular compartments, possibly to mediate a disease-associated phenotype, which is similar to what is seen with PLP1.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endoplasmic reticulum; FAM126A; Hypomyelinating leukodystrophy; Unfolded protein response

Mesh:

Substances:

Year:  2013        PMID: 24417797     DOI: 10.1016/j.jocn.2013.09.014

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  10 in total

1.  Biallelic PI4KA variants cause neurological, intestinal and immunological disease.

Authors:  Claire G Salter; Yiying Cai; Bernice Lo; Guy Helman; Henry Taylor; Amber McCartney; Joseph S Leslie; Andrea Accogli; Federico Zara; Monica Traverso; James Fasham; Joshua A Lees; Matteo P Ferla; Barry A Chioza; Olivia Wenger; Ethan Scott; Harold E Cross; Joanna Crawford; Ilka Warshawsky; Matthew Keisling; Dimitris Agamanolis; Catherine Ward Melver; Helen Cox; Mamoun Elawad; Tamas Marton; Matthew N Wakeling; Dirk Holzinger; Stephan Tippelt; Martin Munteanu; Deyana Valcheva; Christin Deal; Sara Van Meerbeke; Catherine Walsh Vockley; Manish J Butte; Utkucan Acar; Marjo S van der Knaap; G Christoph Korenke; Urania Kotzaeridou; Tamas Balla; Cas Simons; Holm H Uhlig; Andrew H Crosby; Pietro De Camilli; Nicole I Wolf; Emma L Baple
Journal:  Brain       Date:  2021-12-31       Impact factor: 15.255

2.  Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.

Authors:  Michael Nafisinia; Nara Sobreira; Lisa Riley; Wendy Gold; Birgit Uhlenberg; Claudia Weiß; Corinne Boehm; Kristina Prelog; Robert Ouvrier; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

3.  Data on the effect of hypomyelinating leukodystrophy 6 (HLD6)-associated mutations on the TUBB4A properties.

Authors:  Yuki Miyamoto; Tomohiro Torii; Kazuko Kawahara; Nanami Hasegawa; Akito Tanoue; Yoichi Seki; Takako Morimoto; Megumi Funakoshi-Tago; Hiroomi Tamura; Keiichi Homma; Masahiro Yamamoto; Junji Yamauchi
Journal:  Data Brief       Date:  2017-02-16

4.  VCAM1 acts in parallel with CD69 and is required for the initiation of oligodendrocyte myelination.

Authors:  Yuki Miyamoto; Tomohiro Torii; Akito Tanoue; Junji Yamauchi
Journal:  Nat Commun       Date:  2016-11-23       Impact factor: 14.919

5.  Defective myelination in mice harboring hypomyelinating leukodystrophy-associated HSPD1 mutation.

Authors:  Yuki Miyamoto; Kazuko Kawahara; Tomohiro Torii; Junji Yamauchi
Journal:  Mol Genet Metab Rep       Date:  2017-03-24

6.  PP1C and PP2A are p70S6K Phosphatases Whose Inhibition Ameliorates HLD12-Associated Inhibition of Oligodendroglial Cell Morphological Differentiation.

Authors:  Naoto Matsumoto; Yuki Miyamoto; Kohei Hattori; Akihiro Ito; Hironori Harada; Hiroaki Oizumi; Katsuya Ohbuchi; Kazushige Mizoguchi; Junji Yamauchi
Journal:  Biomedicines       Date:  2020-04-16

7.  Rare Neurologic Disease-Associated Mutations of AIMP1 are Related with Inhibitory Neuronal Differentiation Which is Reversed by Ibuprofen.

Authors:  Yu Takeuchi; Marina Tanaka; Nanako Okura; Yasuyuki Fukui; Ko Noguchi; Yoshihiro Hayashi; Tomohiro Torii; Hiroaki Ooizumi; Katsuya Ohbuchi; Kazushige Mizoguchi; Yuki Miyamoto; Junji Yamauchi
Journal:  Medicines (Basel)       Date:  2020-05-06

8.  Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.

Authors:  Naoto Matsumoto; Natsumi Watanabe; Noriko Iibe; Yuriko Tatsumi; Kohei Hattori; Yu Takeuchi; Hiroaki Oizumi; Katsuya Ohbuchi; Tomohiro Torii; Yuki Miyamoto; Junji Yamauchi
Journal:  Biochem Biophys Rep       Date:  2019-11-07

9.  Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease.

Authors:  Kamran Tariq; Bryan W Luikart
Journal:  Explor Neuroprotective Ther       Date:  2021-10-29

10.  A nanodomain-anchored scaffolding complex is required for the function and localization of phosphatidylinositol 4-kinase alpha in plants.

Authors:  Lise C Noack; Vincent Bayle; Laia Armengot; Frédérique Rozier; Adiilah Mamode-Cassim; Floris D Stevens; Marie-Cécile Caillaud; Teun Munnik; Sébastien Mongrand; Roman Pleskot; Yvon Jaillais
Journal:  Plant Cell       Date:  2022-01-20       Impact factor: 12.085

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.